Publications by authors named "Matthew Aspelund"

Claim this Profile
I
Impact of photo-oxidation on long term storage of affinity chromatography media used in multi-specific antibody manufacturing processes.
Kamiyar Rezvani, Matthew T Aspelund

J Chromatogr A· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging light chain binding avidity for control of mispaired byproducts during production of asymmetric bispecific antibodies.
Kamiyar Rezvani, Dominique WuDunn, Alan K Hunter, Matthew T Aspelund

J Chromatogr A· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of compendial nonionic detergents for the replacement of Triton X-100 in bioprocessing.
Alan K Hunter, Kamiyar Rezvani, Matthew T Aspelund, Guoling Xi, Dhanesh Gadre

Biotechnol Prog· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic workflow for studying domain contributions of bispecific antibodies to selectivity in multimodal chromatography.
Siddharth S Parasnavis, Ben Niu, Matthew Aspelund, Wai K Chung, Mark Snyder

Biotechnol Bioeng· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
Mingyan Cao, Conner Parthemore, Yang Jiao, Samuel Korman, Matthew Aspelund

J Pharm Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.
Cassia Andrade, Lindsay Arnold, Dana Motabar, Matthew Aspelund, Alison Tang

Biotechnol Prog· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody fragment removal mediated by mixed mode resins.
Ellen O'Connor, Matthew Aspelund, Frank Bartnik, Mark Berge, Kelly Coughlin

J Chromatogr A· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and scale-up of a commercial fed batch refolding process for an anti-CD22 two chain immunotoxin.
Thomas Linke, Matthew T Aspelund, Christopher Thompson, Guoling Xi, Andrew Fulton

Biotechnol Prog· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovering corn germ enriched in recombinant protein by wet-fractionation.
Ilankovan Paraman, Steven R Fox, Matthew T Aspelund, Charles E Glatz, Lawrence A Johnson

Bioresour Technol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis